Search Results

Test vacuum established in turbine condenser of Unit 1 at Turkey's Akkuyu NPP

On August 25, test vacuum was established in the turbine condenser of Unit 1 at Turkey's Akkuyu Nuclear Power Plant. This operation verified the readiness of the main systems of the turbine unit, creating conditions for subsequent commissioning work. Specialists from TITAN-2 Holding (TITAN-2) established the required vacuum in the condenser and checked the tightness of the vacuum system as well as the thermal and mechanical condition of the turbine. During the test, technical personnel continuously monitored key parameters such as steam pressure, bearing temperatures, thermal expansion of cylinders and rotors, and condenser vacuum level. While the turbine was rotated by the turning gear, experts also verified the operational condition of the turbine flow path. This...

2026-08-27

Ukraine's Nurecab Nuclear Capacity Building Project Completes First Implementation Cycle

On August 20, 2026, the final seminar of the international project Nurecab (Nuclear Capacity Building in Ukraine through European Cooperation) was held in Kyiv. The project is funded by the European Union through the Euratom Research and Training Programme and is incorporated into the Horizon Europe framework. The seminar was held in a hybrid format, with a total of 76 experts, researchers, educators, and representatives of national institutions participating, of whom 26 attended in person in Kyiv and 50 joined via video link. The meeting showcased the project's implementation results and facilitated discussions on nuclear energy education in Ukraine, the development of nuclear science, and...

2026-08-27

Europe Advances Space Nuclear Power Research, Targeting Lunar and Mars Missions

The European Space Agency (ESA) is accelerating its assessment of nuclear energy applications in deep-space missions, focusing on using small nuclear reactors to power spacecraft electric propulsion systems, as well as providing stable energy for future fixed lunar surface facilities and subsequent Mars missions. Existing space missions primarily rely on chemical fuels and solar panels. The former is limited by the amount of propellant that can be carried, while the latter suffers from declining power generation efficiency as spacecraft move farther from the Sun. ESA believes that nuclear power systems could compensate for the shortcomings of both approaches, particularly in long-duration lunar operations and deeper space exploration. ESA completed a nuclear thermal propulsion study last year. In March this year, the agency...

2026-08-27

Japan's Helical Fusion and Tohoku University Launch Social Communication Research on Fusion Energy

Helical Fusion recently announced that it has launched a joint research project with the Takahashi-Kariwara Laboratory of the Graduate School of Engineering at Tohoku University in August 2026, focusing on ideal communication methods for the social implementation of fusion energy. The project is planned to last approximately one year, with a focus on exploring the communication methods, dialogue mechanisms, and decision-making pathways required for fusion energy to move toward social application. According to the project plan, both parties will examine cases of existing advanced technologies in areas such as social acceptance and risk perception to study communication strategies needed for the stable application of fusion energy in future society. The research also plans to introduce...

2026-08-27

South Korea's Daewoong Pharmaceutical Partners with Promedius to Promote AI Osteoporosis Screening Solution Using Chest X-rays

Daewoong Pharmaceutical announced on August 27 that it has signed a sales, distribution, and joint promotion agreement with Promedius, a medical imaging AI company, to promote Osteo Signal, an AI-based osteoporosis risk screening solution using chest X-rays, in South Korea. This partnership also marks Daewoong Pharmaceutical's expansion from its existing osteoporosis treatment business into the AI-assisted diagnostics field. Under the agreement, Daewoong Pharmaceutical will leverage its business network covering medical institutions across South Korea, along with its sales and marketing capabilities, to bring the solution into more clinical settings. Promedius will provide medical imaging AI technical support to assist in its deployment in real-world medical environments.

2026-08-27

Hyogo Medical University Hospital to Launch Japan's First Elekta Evo Linear Accelerator System Treatments

Elekta K.K. announced on August 27 that its high-precision radiation therapy device, the Elekta Evo linear accelerator system, will be installed for the first time in Japan at Hyogo Medical University Hospital, with the first treatment scheduled to commence on September 24, 2026. This marks the entry of this next-generation radiation therapy system into clinical application in Japan. As the number of cancer patients increases, the demand for personalized and precise treatment in the field of radiation therapy continues to rise. The Elekta Evo is positioned as a next-generation radiation therapy system capable of covering both routine and more complex cancer treatment scenarios. The system is equipped with Iris, an AI-driven high-definition imaging technology, which enables clearer visualization of the positional relationships between organs in the patient's body...

2026-08-27

Tohoku University and Rigaku Establish Joint Research Institute for X-ray Metrology

Tohoku University and Rigaku Corporation, a subsidiary of Rigaku Holdings Group, recently announced that they established the "Rigaku-Tohoku University X-ray Metrology Co-Creation Research Institute Beyond The Limits" on August 1, 2026, and commenced joint research. The institute will operate for a period of three years, until July 31, 2029, with the possibility of extension based on research outcomes. According to the announcement, the new institute will focus on upgrading X-ray metrology technologies, establishing new measurement methods, and nurturing the next generation of researchers. As semiconductor devices continue to shrink in size while becoming increasingly multi-layered and multi-material in composition, manufacturing processes are growing more complex, driving rising demand for high-precision, non-destructive evaluation of materials and structures. Existing measurement methods face limitations in evaluating fine structures and precisely analyzing depth-direction structures, making the development of new approaches such as soft X-ray techniques an important direction.

2026-08-27

Canadian Light Source Synchrotron at University of Saskatchewan Receives $3 Million CAD in Upgrade Funding

On August 26, Innovation Saskatchewan announced that it will provide $3 million CAD in funding to the Canadian Light Source synchrotron at the University of Saskatchewan to support the installation of an advanced solid-state amplifier, advancing the facility's upgrade efforts. According to reports, this solid-state amplifier is a key component of the Canadian Light Source's core particle accelerator and will support the operation of its 22 synchrotron radiation beamlines. The upgrade is expected to enhance facility performance, operational reliability, and energy efficiency, further strengthening its capacity for cutting-edge scientific research. The Canadian Light Source is Canada's only synchrotron facility. Synchrotrons use electromagnetic fields and radiofrequency waves to accelerate electrons to near the speed of light, keeping them in a circular orbit; as electrons move, they generate high-brightness, highly focused synchrotron radiation beams, which are directed to different experimental beamlines to help researchers study material structures and properties at the atomic scale.

2026-08-27

Sichuan Huadu Nuclear Energy Wins Control Rod Drive Mechanism Orders for 4 Nuclear Power Units

On August 24, news came from Sichuan Huadu Nuclear Equipment Manufacturing Co., Ltd., located in Dujiangyan, Chengdu, Sichuan, that the company has won the orders for control rod drive mechanisms for 4 units among the first batch of nuclear power units approved for construction during the 15th Five-Year Plan period in China, with a total new contract value of 504 million yuan. The winning projects include Units 3 and 4 of Zhejiang Jinqimen Nuclear Power Plant, as well as Units 1 and 2 of Phase I of Liaoning Zhuanghe Nuclear Power. According to the previous approval arrangement by the State Council Executive Meeting, the new batch of nuclear power projects involves a total of 4 projects and 8 units, including Phase II of Zhejiang Jinqimen Nuclear Power, Phase III of Guangdong Taipingling Nuclear Power, Phase I of Liaoning Zhuanghe Nuclear Power, and Phase I of Shandong Laiyang Nuclear Power, all adopting China's self-developed third-generation nuclear power technology...

2026-08-27

Huzhou, Zhejiang Launches Phase I "Drug-Device Combination" Clinical Trial for the Province's First BNCT System

Recently, the Boron Neutron Tumor Treatment Center at Huzhou Hospital Affiliated to Zhejiang University School of Medicine has drawn attention with the introduction of the province's first Boron Neutron Capture Therapy (BNCT) system. Previously, the system had already initiated a Phase I BNCT drug-device combination clinical trial. According to the system developer, Huapeng Neutron Technology (Hangzhou) Co., Ltd., BNCT is a radiotherapy technique combining drugs and devices, with its core lying in the coordinated use of boron-containing drugs and neutron irradiation. After entering the human body, the boron-containing drug can be absorbed by tumor cells; subsequent neutron beam irradiation triggers a localized reaction to achieve targeted radiotherapy against tumor cells. Unlike conventional radiotherapy, which typically employs fractionated irradiation over a longer treatment course, BNCT emphasizes selective targeting of tumor cells, aiming to reduce damage to surrounding healthy tissues and lower radiotherapy-related side effects such as hair loss and immunosuppression.

2026-08-27

NPCIL plans new design unit to support indigenous PHWR deployment

Months after India's tightly regulated nuclear power sector opened up to private capital, Nuclear Power Corporation of India Limited (NPCIL) plans to establish a new design unit to provide technical support to private companies and state governments interested in adopting indigenous nuclear reactor technology. The proposal for this business segment is still under approval. Under the plan, the new unit will offer technical support, design review, and quality assurance services to entities seeking access to Pressurized Heavy Water Reactor (PHWR) technology and related engineering expertise. With the release of draft rules under the Sustainable Harmonious Advancement of Nuclear Technology in India (SHANTI) Act, the legal framework for licensing new nuclear projects in India is expected to be further clarified, and NPCIL also hopes to reorganize its internal functions accordingly.

2026-08-27

Bangladesh Highlights Potential of Nuclear Technology for Maritime Applications at ATLAS Ministerial Meeting

On August 26, local time, Bangladesh's Minister of Science and Technology, Faqrul Mahbub Anam, stated at the 2026 Ministerial Launch of the Licensing of Atomic Technology for Marine Applications (ATLAS) held in Washington, D.C., USA, that Bangladesh is committed to responsible participation in the global nuclear dialogue and believes that emerging nuclear technologies hold significant potential in the field of maritime applications. Anam stated that in the face of challenges such as climate change, energy security, and growing energy demand, the importance of nuclear energy in reducing emissions and ensuring reliable energy supply is rising. Advanced nuclear technologies, including Small Modular Reactors (SMRs), can provide stable low-carbon electricity and support economic growth, poverty reduction...

2026-08-27

IAEA Launches ATLAS Initiative to Advance Nuclear Energy Maritime Applications

The International Atomic Energy Agency (IAEA) launched the Atomic Technology for Maritime Applications Licensing Scheme (ATLAS) on August 26 in Washington, D.C., United States, aiming to support the safe, reliable, and peaceful use of nuclear energy in civilian vessels and floating nuclear power plants. The two-day ATLAS ministerial launch event, hosted by the United States, attracted approximately 600 delegates from over 50 countries, including international organizations, nuclear and maritime industry enterprises, port authorities, and relevant regulatory and policy departments. The IAEA stated that as nuclear-powered ships and floating nuclear power plants gain increasing attention, closer coordination mechanisms between the nuclear and maritime communities are needed. Maritime shipping carries approximately 80% of global trade volume, and maritime trade demand continues to grow at around 2% annually...

2026-08-27

Malaysia Advances Nuclear Energy Workforce Planning Capacity Building

The International Atomic Energy Agency (IAEA) recently held a national workshop on nuclear energy human resource planning in Malaysia to help the country enhance its workforce forecasting and capacity building for existing and future nuclear applications. The workshop was held from 17 to 21 August 2026 over five days, with participants from MyPOWER Corporation, the Malaysian Nuclear Agency, regulatory bodies, national utilities, and academic and training institutions. The five-day workshop was held in Malaysia from 17 to 21 August 2026, with participants including representatives from MyPOWER Corp...

2026-08-27

Moffitt Cancer Center in the U.S. Launches $600 Million Radiopharmaceutical Program

Moffitt Cancer Center in Tampa, Florida, recently announced the launch of a new radiopharmaceutical program, planning to accelerate radiopharmaceutical research, development, and clinical translation through a total infrastructure investment of $600 million. The program will be advanced at the Speros campus of Moffitt Cancer Center in Pasco County, Florida. The campus spans 775 acres, and the related investment will support the development of radiopharmaceutical research and development capabilities, including the construction of new radiochemistry laboratories within the Moffitt Discovery and Innovation Center, which opens this fall. The innovation center has a building area of approximately 255,000 square feet. The program funding will also support the planned comprehensive theranostics center...

2026-08-27